Posted by Anyuser on October 10, 2002, at 8:41:01
In reply to Lexapro and Celexa relative side-effects » pharmrep, posted by dr. dave on October 10, 2002, at 8:10:49
From docguide.com:
"Escitalopram 10 to 20 mg/day for treatment of moderately to severely depressed subjects showed ongoing and increasing efficacy throughout a 12-month, open-label study conducted at 97 sites.
"The study's findings were reported at the 15th Congress of the European College of Neuropsychopharmacology (ECNP).
"'The remission rate among the subjects continuing in the open-label study reached 86 percent by week 52,' said lead investigator Alan Wade, MBChB, director at the CPS Clinical Research Centre, in Glasgow, United Kingdom. 'This long-term, primary care-based data begins to fill out the picture of escitalopram as a drug that raises the bar of expectations for effective and tolerable treatment of this group of patients.'"
This study was funded by Lundbeck.
Do you think this is news? Good science?
I wish we could see the data re clinical experience, but it is not reported.
poster:Anyuser
thread:109458
URL: http://www.dr-bob.org/babble/20021006/msgs/123045.html